Authors
Loading...
Observational findings reveal high PTPN11 protein levels reduce survival rates in acute myelogenous leukemia, suggesting therapeutic targets may benefit more patients.
Magalhães et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: